Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Glucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs.

Bornebusch AB, Fink-Jensen A, Wörtwein G, Seeley RJ, Thomsen M.

eNeuro. 2019 Apr 24;6(2). pii: ENEURO.0443-18.2019. doi: 10.1523/ENEURO.0443-18.2019. eCollection 2019 Mar-Apr.

2.

The effect of glucagon-like peptide-1 (GLP-1) receptor agonists on substance use disorder (SUD)-related behavioural effects of drugs and alcohol: A systematic review.

Brunchmann A, Thomsen M, Fink-Jensen A.

Physiol Behav. 2019 Jul 1;206:232-242. doi: 10.1016/j.physbeh.2019.03.029. Epub 2019 Apr 1. Review.

PMID:
30946836
3.

Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole: 12-Week Results From the Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis (TEA) Trial.

Jensen KG, Correll CU, Rudå D, Klauber DG, Decara MS, Fagerlund B, Jepsen JRM, Eriksson F, Fink-Jensen A, Pagsberg AK.

J Am Acad Child Adolesc Psychiatry. 2019 Nov;58(11):1062-1078. doi: 10.1016/j.jaac.2019.01.015. Epub 2019 Mar 9.

PMID:
30858012
4.

High prevalence of prediabetes and metabolic abnormalities in overweight or obese schizophrenia patients treated with clozapine or olanzapine.

Larsen JR, Svensson CK, Vedtofte L, Jakobsen ML, Jespersen HS, Jakobsen MI, Koyuncu K, Schjerning O, Nielsen J, Ekstrøm CT, Holst JJ, Correll CU, Vilsbøll T, Fink-Jensen A.

CNS Spectr. 2018 Dec 31:1-12. doi: 10.1017/S1092852918001311. [Epub ahead of print]

PMID:
30596361
5.

Effects of glucagon-like peptide 1 analogs on alcohol intake in alcohol-preferring vervet monkeys.

Thomsen M, Holst JJ, Molander A, Linnet K, Ptito M, Fink-Jensen A.

Psychopharmacology (Berl). 2019 Feb;236(2):603-611. doi: 10.1007/s00213-018-5089-z. Epub 2018 Oct 31.

PMID:
30382353
6.

One-year follow-up on liraglutide treatment for prediabetes and overweight/obesity in clozapine- or olanzapine-treated patients.

Svensson CK, Larsen JR, Vedtofte L, Jakobsen MSL, Jespersen HR, Jakobsen MI, Koyuncu K, Schjerning O, Nielsen J, Ekstrøm CT, Correll CU, Vilsbøll T, Fink-Jensen A.

Acta Psychiatr Scand. 2019 Jan;139(1):26-36. doi: 10.1111/acps.12982. Epub 2018 Nov 28.

PMID:
30374965
7.

Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors: A systematic review and individual participant data meta-analysis.

Siskind D, Hahn M, Correll CU, Fink-Jensen A, Russell AW, Bak N, Broberg BV, Larsen J, Ishøy PL, Vilsbøll T, Knop FK, Kisely S, Ebdrup BH.

Diabetes Obes Metab. 2019 Feb;21(2):293-302. doi: 10.1111/dom.13522. Epub 2018 Oct 7.

PMID:
30187620
8.

Does glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: study protocol of a randomised, double-blinded, placebo-controlled clinical trial.

Antonsen KK, Klausen MK, Brunchmann AS, le Dous N, Jensen ME, Miskowiak KW, Fisher PM, Thomsen GK, Rindom H, Fahmy TP, Vollstaedt-Klein S, Benveniste H, Volkow ND, Becker U, Ekstrøm C, Knudsen GM, Vilsbøll T, Fink-Jensen A.

BMJ Open. 2018 Jul 16;8(7):e019562. doi: 10.1136/bmjopen-2017-019562.

9.

PICK1-Deficient Mice Exhibit Impaired Response to Cocaine and Dysregulated Dopamine Homeostasis.

Jensen KL, Sørensen G, Dencker D, Owens WA, Rahbek-Clemmensen T, Brett Lever M, Runegaard AH, Riis Christensen N, Weikop P, Wörtwein G, Fink-Jensen A, Madsen KL, Daws L, Gether U, Rickhag M.

eNeuro. 2018 Jun 11;5(3). pii: ENEURO.0422-17.2018. doi: 10.1523/ENEURO.0422-17.2018. eCollection 2018 May-Jun.

10.

Expression and localization of CB1R, NAPE-PLD, and FAAH in the vervet monkey nucleus accumbens.

Kucera R, Bouskila J, Elkrief L, Fink-Jensen A, Palmour R, Bouchard JF, Ptito M.

Sci Rep. 2018 Jun 6;8(1):8689. doi: 10.1038/s41598-018-26826-2.

11.

Sudden Cardiac Death: Pharmacotherapy and Proarrhythmic Drugs: A Nationwide Cohort Study in Denmark.

Risgaard B, Winkel BG, Jabbari R, Lynge TH, Wissenberg M, Glinge C, Haunsø S, Behr ER, Fink-Jensen A, Gislason GH, Tfelt-Hansen J.

JACC Clin Electrophysiol. 2017 May;3(5):473-481. doi: 10.1016/j.jacep.2016.12.023. Epub 2017 Mar 29.

12.

Eosinopenia in women with schizophrenia: Drug-induced or a sign of gender specific difference in pathogenesis?

Jakobsen MI, Fink-Jensen A.

Schizophr Res. 2018 Jul;197:601-602. doi: 10.1016/j.schres.2018.02.007. Epub 2018 Feb 26. No abstract available.

PMID:
29490882
13.

Effects of Prenatal Alcohol Exposure on the Visual System of Monkeys Measured at Different Stages of Development.

Harrar V, Elkrief L, Bouskila J, Kucera R, Fink-Jensen A, Bouchard JF, Palmour R, Ptito M.

Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6282-6291. doi: 10.1167/iovs.17-22181.

PMID:
29242902
14.

Change and dispersion of QT interval during treatment with quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: results from the TEA trial.

Jensen KG, Gärtner S, Correll CU, Rudå D, Klauber DG, Stentebjerg-Olesen M, Fagerlund B, Jepsen JR, Fink-Jensen A, Juul K, Pagsberg AK.

Psychopharmacology (Berl). 2018 Mar;235(3):681-693. doi: 10.1007/s00213-017-4784-5. Epub 2017 Nov 29.

PMID:
29185022
15.

Ketogenic Diet Suppresses Alcohol Withdrawal Syndrome in Rats.

Dencker D, Molander A, Thomsen M, Schlumberger C, Wortwein G, Weikop P, Benveniste H, Volkow ND, Fink-Jensen A.

Alcohol Clin Exp Res. 2018 Feb;42(2):270-277. doi: 10.1111/acer.13560. Epub 2017 Dec 23.

PMID:
29160944
16.

Substance use among Danish psychiatric patients: a cross-sectional study.

Sørensen T, Jespersen HSR, Vinberg M, Becker U, Ekholm O, Fink-Jensen A.

Nord J Psychiatry. 2018 Feb;72(2):130-136. doi: 10.1080/08039488.2017.1400098. Epub 2017 Nov 9.

PMID:
29117747
17.

Prospective psychometric characterization of hip and knee arthroplasty patients.

Gylvin SH, Fink-Jensen A, Kehlet H, Jørgensen CC, Laursen MB, Gromov K, Schroder HM, Høvsgaard SJ, Wede HR, Kyle PR, Bech P.

Nord J Psychiatry. 2018 Jan;72(1):39-44. doi: 10.1080/08039488.2017.1381149. Epub 2017 Oct 12.

PMID:
29022751
18.

Liraglutide for the Treatment of Antipsychotic Drug-Induced Weight Gain-Reply.

Fink-Jensen A, Correll CU, Vilsbøll T.

JAMA Psychiatry. 2017 Nov 1;74(11):1173-1174. doi: 10.1001/jamapsychiatry.2017.2702. No abstract available.

PMID:
28973062
19.

The Role of Psychiatric Diagnoses for Outcome After Hip and Knee Arthroplasty.

Gylvin SH, Jørgensen CC, Fink-Jensen A, Gislason GH, Kehlet H; Lundbeck Foundation Centre for Fast-track Hip and Knee Replacement Collaborative Group.

J Arthroplasty. 2017 Dec;32(12):3611-3615. doi: 10.1016/j.arth.2017.06.051. Epub 2017 Jul 8.

PMID:
28800859
20.

The glucagon-like peptide 1 receptor agonist Exendin-4 decreases relapse-like drinking in socially housed mice.

Thomsen M, Dencker D, Wörtwein G, Weikop P, Egecioglu E, Jerlhag E, Fink-Jensen A, Molander A.

Pharmacol Biochem Behav. 2017 Sep;160:14-20. doi: 10.1016/j.pbb.2017.07.014. Epub 2017 Aug 1.

PMID:
28778739
21.

Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial.

Larsen JR, Vedtofte L, Jakobsen MSL, Jespersen HR, Jakobsen MI, Svensson CK, Koyuncu K, Schjerning O, Oturai PS, Kjaer A, Nielsen J, Holst JJ, Ekstrøm CT, Correll CU, Vilsbøll T, Fink-Jensen A.

JAMA Psychiatry. 2017 Jul 1;74(7):719-728. doi: 10.1001/jamapsychiatry.2017.1220.

22.

Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial.

Pagsberg AK, Jeppesen P, Klauber DG, Jensen KG, Rudå D, Stentebjerg-Olesen M, Jantzen P, Rasmussen S, Saldeen EA, Lauritsen MG, Bilenberg N, Stenstrøm AD, Nyvang L, Madsen S, Werge TM, Lange T, Gluud C, Skoog M, Winkel P, Jepsen JRM, Fagerlund B, Correll CU, Fink-Jensen A.

Lancet Psychiatry. 2017 Aug;4(8):605-618. doi: 10.1016/S2215-0366(17)30166-9. Epub 2017 Jun 7.

PMID:
28599949
23.

Muscarinic receptor M4 positive allosteric modulators attenuate central effects of cocaine.

Dall C, Weikop P, Dencker D, Molander AC, Wörtwein G, Conn PJ, Fink-Jensen A, Thomsen M.

Drug Alcohol Depend. 2017 Jul 1;176:154-161. doi: 10.1016/j.drugalcdep.2017.03.014. Epub 2017 May 16.

24.

Antipsychotic treatment of schizotypy and schizotypal personality disorder: a systematic review.

Jakobsen KD, Skyum E, Hashemi N, Schjerning O, Fink-Jensen A, Nielsen J.

J Psychopharmacol. 2017 Apr;31(4):397-405. doi: 10.1177/0269881117695879. Epub 2017 Mar 14. Review.

PMID:
28347257
25.

Acute Antipsychotic Treatment of Children and Adolescents With Schizophrenia-Spectrum Disorders: A Systematic Review and Network Meta-Analysis.

Pagsberg AK, Tarp S, Glintborg D, Stenstrøm AD, Fink-Jensen A, Correll CU, Christensen R.

J Am Acad Child Adolesc Psychiatry. 2017 Mar;56(3):191-202. doi: 10.1016/j.jaac.2016.12.013. Epub 2016 Dec 29. Review.

PMID:
28219485
26.

Psychopharmacologic treatment and blood transfusion in fast-track total hip and knee arthroplasty.

Gylvin SH, Jørgensen CC, Fink-Jensen A, Johansson PI, Kehlet H; Lundbeck Foundation Centre for Fast-track Hip and Knee Replacement Collaborative Group.

Transfusion. 2017 Apr;57(4):971-976. doi: 10.1111/trf.13992. Epub 2017 Jan 31.

PMID:
28145024
27.

[Benzodiazepines should still be first-line treatment for alcohol withdrawal].

Askgaard G, Pottegård A, Fink-Jensen A.

Ugeskr Laeger. 2017 Jan 16;179(3). pii: V07160465. Review. Danish.

PMID:
28115043
28.

Pretreatment Cardiometabolic Status in Youth With Early-Onset Psychosis: Baseline Results From the TEA Trial.

Jensen KG, Correll CU, Rudå D, Klauber DG, Stentebjerg-Olesen M, Fagerlund B, Jepsen JRM, Fink-Jensen A, Pagsberg AK.

J Clin Psychiatry. 2017 Sep/Oct;78(8):e1035-e1046. doi: 10.4088/JCP.15m10479.

PMID:
28102978
29.

The significance of sampling time in therapeutic drug monitoring of clozapine.

Jakobsen MI, Larsen JR, Svensson CK, Johansen SS, Linnet K, Nielsen J, Fink-Jensen A.

Acta Psychiatr Scand. 2017 Feb;135(2):159-169. doi: 10.1111/acps.12673. Epub 2016 Dec 6.

PMID:
27922183
30.

The relationship between self-reported childhood adversities, adulthood psychopathology and psychological stress markers in patients with schizophrenia.

Seidenfaden D, Knorr U, Soendergaard MG, Poulsen HE, Fink-Jensen A, Jorgensen MB, Jorgensen A.

Compr Psychiatry. 2017 Jan;72:48-55. doi: 10.1016/j.comppsych.2016.09.009. Epub 2016 Sep 24.

PMID:
27736667
31.

Adverse events in children and adolescents treated with quetiapine: an analysis of adverse drug reaction reports from the Danish Medicines Agency database.

Jakobsen KD, Wallach-Kildemoes H, Bruhn CH, Hashemi N, Pagsberg AK, Fink-Jensen A, Nielsen J.

Int Clin Psychopharmacol. 2017 Mar;32(2):103-106. doi: 10.1097/YIC.0000000000000148.

PMID:
27685179
32.

Neurological, Metabolic, and Psychiatric Adverse Events in Children and Adolescents Treated With Aripiprazole.

Jakobsen KD, Bruhn CH, Pagsberg AK, Fink-Jensen A, Nielsen J.

J Clin Psychopharmacol. 2016 Oct;36(5):496-9. doi: 10.1097/JCP.0000000000000548.

PMID:
27504593
33.

[There is a need for a strengthened and unified treatment of dual diagnosis patients].

Fink-Jensen A.

Ugeskr Laeger. 2016 Jul 25;178(30). pii: V68165. Danish. No abstract available.

PMID:
27460574
34.

Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels.

Reddy IA, Pino JA, Weikop P, Osses N, Sørensen G, Bering T, Valle C, Bluett RJ, Erreger K, Wortwein G, Reyes JG, Graham D, Stanwood GD, Hackett TA, Patel S, Fink-Jensen A, Torres GE, Galli A.

Transl Psychiatry. 2016 May 17;6:e809. doi: 10.1038/tp.2016.86.

35.

Glucagon-like peptide-1 (GLP-1) analogues: A potential new treatment for alcohol use disorder?

Fink-Jensen A, Vilsbøll T.

Nord J Psychiatry. 2016 Nov;70(8):561-2. doi: 10.1080/08039488.2016.1176252. Epub 2016 May 6. No abstract available.

PMID:
27151395
36.

Clinical Characteristics and Predictors of Outcome of Schizophrenia-Spectrum Psychosis in Children and Adolescents: A Systematic Review.

Stentebjerg-Olesen M, Pagsberg AK, Fink-Jensen A, Correll CU, Jeppesen P.

J Child Adolesc Psychopharmacol. 2016 Jun;26(5):410-27. doi: 10.1089/cap.2015.0097. Epub 2016 May 2. Review.

PMID:
27136403
37.

Alcohol consumption among patients with diabetes: a survey-based cross-sectional study of Danish adults with diabetes.

Jakobsen ML, Larsen JR, Glümer C, Juel K, Ekholm O, Vilsbøll T, Becker U, Fink-Jensen A.

Scand J Public Health. 2016 Jul;44(5):517-24. doi: 10.1177/1403494816645223. Epub 2016 Apr 25.

PMID:
27113964
38.

Phenobarbital compared to benzodiazepines in alcohol withdrawal treatment: A register-based cohort study of subsequent benzodiazepine use, alcohol recidivism and mortality.

Askgaard G, Hallas J, Fink-Jensen A, Molander AC, Madsen KG, Pottegård A.

Drug Alcohol Depend. 2016 Apr 1;161:258-64. doi: 10.1016/j.drugalcdep.2016.02.016. Epub 2016 Feb 18.

PMID:
26922279
39.

Psychiatric disease as a risk factor in fast-track hip and knee replacement.

Gylvin SH, Jørgensen CC, Fink-Jensen A, Kehlet H.

Acta Orthop. 2016 Oct;87(5):439-43. doi: 10.3109/17453674.2016.1151292. Epub 2016 Feb 22. Review.

40.

Sudden cardiac death in young adults with previous hospital-based psychiatric inpatient and outpatient treatment: a nationwide cohort study from Denmark.

Risgaard B, Waagstein K, Winkel BG, Jabbari R, Lynge TH, Glinge C, Albert C, Correll CU, Haunsø S, Fink-Jensen A, Tfelt-Hansen J.

J Clin Psychiatry. 2015 Sep;76(9):e1122-9. doi: 10.4088/JCP.14m09742.

PMID:
26455676
41.

Treatment of adult patients with schizophrenia and complex mental health needs - A national clinical guideline.

Baandrup L, Østrup Rasmussen J, Klokker L, Austin S, Bjørnshave T, Fuglsang Bliksted V, Fink-Jensen A, Hedegaard Fohlmann A, Peter Hansen J, Kristine Nielsen M, Sandsten KE, Schultz V, Voss-Knude S, Nordentoft M.

Nord J Psychiatry. 2016;70(3):231-40. doi: 10.3109/08039488.2015.1074285. Epub 2015 Sep 2.

PMID:
26328910
42.

Regional brain volumes, diffusivity, and metabolite changes after electroconvulsive therapy for severe depression.

Jorgensen A, Magnusson P, Hanson LG, Kirkegaard T, Benveniste H, Lee H, Svarer C, Mikkelsen JD, Fink-Jensen A, Knudsen GM, Paulson OB, Bolwig TG, Jorgensen MB.

Acta Psychiatr Scand. 2016 Feb;133(2):154-164. doi: 10.1111/acps.12462. Epub 2015 Jul 3.

PMID:
26138003
43.

The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice.

Sørensen G, Reddy IA, Weikop P, Graham DL, Stanwood GD, Wortwein G, Galli A, Fink-Jensen A.

Physiol Behav. 2015 Oct 1;149:262-8. doi: 10.1016/j.physbeh.2015.06.013. Epub 2015 Jun 11.

44.

Asymmetric dimethylarginine in somatically healthy schizophrenia patients treated with atypical antipsychotics: a case-control study.

Jorgensen A, Knorr U, Soendergaard MG, Lykkesfeldt J, Fink-Jensen A, Poulsen HE, Jorgensen MB, Olsen NV, Staalsø JM.

BMC Psychiatry. 2015 Apr 3;15:67. doi: 10.1186/s12888-015-0455-4.

45.

Antipsychotic-like effect of the muscarinic acetylcholine receptor agonist BuTAC in non-human primates.

Andersen MB, Croy CH, Dencker D, Werge T, Bymaster FP, Felder CC, Fink-Jensen A.

PLoS One. 2015 Apr 16;10(4):e0122722. doi: 10.1371/journal.pone.0122722. eCollection 2015.

46.

Corrected QT changes during antipsychotic treatment of children and adolescents: a systematic review and meta-analysis of clinical trials.

Jensen KG, Juul K, Fink-Jensen A, Correll CU, Pagsberg AK.

J Am Acad Child Adolesc Psychiatry. 2015 Jan;54(1):25-36. doi: 10.1016/j.jaac.2014.10.002. Epub 2014 Oct 16. Review.

PMID:
25524787
47.

Enhanced self-administration of alcohol in muscarinic acetylcholine M4 receptor knockout mice.

de la Cour C, Sørensen G, Wortwein G, Weikop P, Dencker D, Fink-Jensen A, Molander A.

Eur J Pharmacol. 2015 Jan 5;746:1-5. doi: 10.1016/j.ejphar.2014.10.050. Epub 2014 Nov 20.

PMID:
25445043
48.

Antipsychotic treatment for children and adolescents with schizophrenia spectrum disorders: protocol for a network meta-analysis of randomised trials.

Pagsberg AK, Tarp S, Glintborg D, Stenstrøm AD, Fink-Jensen A, Correll CU, Christensen R.

BMJ Open. 2014 Oct 10;4(10):e005708. doi: 10.1136/bmjopen-2014-005708. Review.

49.

Medicinsk behandling af børn og unge med psykose (RADS-vejledning).

Pagsberg AK, Glintborg D, Fink-Jensen A, Stenstrøm AD.

Ugeskr Laeger. 2014 Jun 2;176(11A). pii: V66218. Danish. No abstract available.

PMID:
25186668
50.

Quetiapine versus aripiprazole in children and adolescents with psychosis--protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial.

Pagsberg AK, Jeppesen P, Klauber DG, Jensen KG, Rudå D, Stentebjerg-Olesen M, Jantzen P, Rasmussen S, Saldeen EA, Lauritsen MB, Bilenberg N, Stenstrøm AD, Pedersen J, Nyvang L, Madsen S, Lauritsen MB, Vernal DL, Thomsen PH, Paludan J, Werge TM, Winge K, Juul K, Gluud C, Skoog M, Wetterslev J, Jepsen JR, Correll CU, Fink-Jensen A, Fagerlund B.

BMC Psychiatry. 2014 Jul 11;14:199. doi: 10.1186/1471-244X-14-199.

Supplemental Content

Loading ...
Support Center